Get the Stockscreener App
1.39
0.71%
-0.01
After Hours:
1.41
0.02
+1.44%
Opko Health Inc stock is traded at $1.39, with a volume of 2.72M.
It is down -0.71% in the last 24 hours and down -10.90% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.40
Open:
$1.37
24h Volume:
2.72M
Relative Volume:
1.24
Market Cap:
$1.10B
Revenue:
$711.41M
Net Income/Loss:
$-133.73M
P/E Ratio:
-7.3158
EPS:
-0.19
Net Cash Flow:
$-199.99M
1W Performance:
-3.47%
1M Performance:
-10.90%
6M Performance:
+0.36%
1Y Performance:
-6.08%
1-Day Range:
$1.37
$1.43
1-Week Range:
$1.35
$1.50
52-Week Range:
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.39 | 1.07B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
Will OPKO Health Inc. stock see insider buyingEarnings Performance Report & Risk Managed Trade Strategies - newser.com
Why analysts remain bullish on OPKO Health Inc. stockBond Market & Growth-Oriented Investment Plans - newser.com
Insider Buying: OPKO Health Chairman & CEO Bought US$213k Of Shares - simplywall.st
News impact scoring models applied to OPKO Health Inc.July 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Using Bollinger Bands to evaluate OPKO Health Inc.Quarterly Trade Summary & Long-Term Capital Growth Strategies - newser.com
Is OPKO Health Inc. stock gaining market shareInsider Selling & Technical Pattern Based Buy Signals - newser.com
How to use Fibonacci retracement on OPKO Health Inc.Chart Signals & Long-Term Investment Growth Plans - newser.com
How currency fluctuations impact OPKO Health Inc. stockJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Some OPKO Health, Inc. (NASDAQ:OPK) Analysts Just Made A Major Cut To Next Year's Estimates - Yahoo Finance
Is OPKO Health Inc. (XCY) stock a defensive play amid uncertaintyMarket Volume Report & Expert Curated Trade Setups - newser.com
How OPKO Health Inc. (XCY) stock performs during market turbulenceEarnings Risk Report & Detailed Earnings Play Strategies - newser.com
Is OPKO Health Inc. building a consolidation baseMarket Rally & Weekly High Return Opportunities - newser.com
Can OPKO Health Inc. (XCY) stock double in coming yearsQuarterly Trade Review & AI Forecast for Swing Trade Picks - newser.com
Published on: 2025-11-03 06:51:40 - newser.com
Is OPKO Health Inc. stock supported by strong fundamentalsJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
Top chart patterns to watch in OPKO Health Inc.July 2025 EndofMonth & Low Drawdown Momentum Ideas - newser.com
Regression analysis insights on OPKO Health Inc. performanceJuly 2025 Volume & Fast Exit and Entry Strategy Plans - newser.com
Why pension funds invest in OPKO Health Inc. (XCY) stockWeekly Trade Review & Entry Point Confirmation Signals - newser.com
HC Wainwright Increases Earnings Estimates for OPKO Health - MarketBeat
Brokers Issue Forecasts for OPKO Health FY2025 Earnings - MarketBeat
Can technical indicators confirm OPKO Health Inc.’s reversalWeekly Gains Report & Capital Efficiency Focused Strategies - newser.com
Can OPKO Health Inc. (XCY) stock hold up in economic slowdownSell Signal & Free Safe Entry Trade Signal Reports - newser.com
Will OPKO Health Inc. stock benefit from green energy trendsEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Will OPKO Health Inc. (XCY) stock enhance shareholder valueTrade Exit Summary & Real-Time Market Sentiment Reports - newser.com
How to read the order book for OPKO Health Inc.2025 Performance Recap & Entry Point Strategy Guides - newser.com
OPKO Health (NASDAQ:OPK) Rating Increased to Hold at Wall Street Zen - MarketBeat
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat
Will OPKO Health Inc. (XCY) stock beat growth indexes2025 Performance Recap & High Accuracy Trade Alerts - newser.com
OPKO Health (OPK) Is Down 9.3% After Regeneron Collaboration and Asset Sale Announcement – Has the Bull Case Changed? - Sahm
Can a trend reversal in OPKO Health Inc. lead to recoveryBull Run & Verified Technical Signals - newser.com
Opko Health director Frost buys $213k in shares By Investing.com - Investing.com Canada
OPKO Health, Inc. (OPK) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
Opko Health director Frost buys $213k in shares - Investing.com
OPKO Health Reports Q3 2025 Earnings and Strategic Moves - MSN
Is OPKO’s Regeneron Deal and Asset Sale Shifting the Investment Case for OPKO Health (OPK)? - Yahoo Finance
OPKO Health Shares Fall After Jefferies Downgrade - MarketScreener
Jefferies Downgrades OPK: Price Target Lowered by 20% | OPK Stoc - GuruFocus
Barrington Research Reiterates "Outperform" Rating for OPKO Health (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Q3 2025 Earnings Call Transcript - Insider Monkey
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Opko Health Inc Stock (OPK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Feb 28 '25 |
Buy |
1.71 |
67,434 |
115,312 |
213,301,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 28 '25 |
Buy |
1.47 |
47,537 |
70,060 |
213,234,014 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 17 '25 |
Buy |
1.47 |
150,000 |
220,425 |
213,186,477 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Jan 15 '25 |
Buy |
1.48 |
500,000 |
740,850 |
213,036,477 |
0.45%
6.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):